Thursday, October 25th, the penny stock of Galena Biopharma Inc. (GALE), already up 54.68% since our June 5th alert, received additional Wall Street coverage. Analysts at McNicoll Lewis & Vlak, MLV Capital, initiated coverage with a “buy” rating and a $6.00 price target on GALE stock — a 179% upside and $2 more ...
OCT